<DOC>
<DOCNO>EP-0659182</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PIPERAZINE DERIVATIVES AND SALTS THEREOF.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31505	A61K31505	A61P300	A61P300	A61P1300	A61P1302	A61P1500	A61P1500	A61P3500	A61P3500	C07D20900	C07D20920	C07D24100	C07D24108	C07D40300	C07D40306	C07D40500	C07D40512	C07D41700	C07D41712	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P3	A61P3	A61P13	A61P13	A61P15	A61P15	A61P35	A61P35	C07D209	C07D209	C07D241	C07D241	C07D403	C07D403	C07D405	C07D405	C07D417	C07D417	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
An object of the present invention is to provide piperazine derivative and salt thereof having inhibitory effect against superoxide radicals (O2
<
-
>
). The piperazine derivative of the present invention is represented by formula (1) (wherein R
<
1
>
 is a lower alkyl group; R
<
2
>
 is a phenyl-lower alkyl group which may have 1 to 3 substituents, on the phenyl ring, selected from the group consisting of a hydroxyl group, a phenyl-lower alkoxy group, a lower alkyl group, a lower alkoxy group and a halogen atom; R
<
3
>
 is a hydrogen atom, a lower alkyl group or a phenyl-lower alkyl group; and R
<
4
>
 is a hydroxyl group, a phenyl-lower alkoxy group or a tetrahydropyranyloxy group).
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OTSUKA PHARMA CO LTD
</APPLICANT-NAME>
<APPLICANT-NAME>
OTSUKA PHARMACEUTICAL CO., LTD.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
MIYAZAKI TOSHIKI
</INVENTOR-NAME>
<INVENTOR-NAME>
MORISUE MASATOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKANO YOSHIMASA
</INVENTOR-NAME>
<INVENTOR-NAME>
TAMURA KATSUMI
</INVENTOR-NAME>
<INVENTOR-NAME>
TONE HITOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
MIYAZAKI, TOSHIKI
</INVENTOR-NAME>
<INVENTOR-NAME>
MORISUE, MASATOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKANO, YOSHIMASA
</INVENTOR-NAME>
<INVENTOR-NAME>
TAMURA, KATSUMI
</INVENTOR-NAME>
<INVENTOR-NAME>
TONE, HITOSHI
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
 DESCRIPTIONTITLE OF THE INVENTIONPIPERAZINE DERIVATIVES AND SALTS THEREOFFIELD OF THE INDUSTRIAL UTILIZATIONThe present invention relates to novel piperazine derivatives and salts thereof.BACKGROUND ARTThere have been known some piperazine derivatives having chemical structural formulae similar to those of the piperazine derivatives of the present invention, from the following prior art references, i.e. EP-A2-303250 and U.S. Patent No. 5,021,419.DISCLOSURE OF THE INVENTIONThe present invention provides piperazine derivatives and salts thereof, which are novel and are not known in prior art references. Said piperazine derivatives are represented by the following general formulae (1) and (2):
 wherein Ri is a lower alkyl group; 

 R2 is a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a hydroxyl group, a phenyl- lower alkoxy group, a lower alkyl group, a lower alkoxy group and a halogen atom, an i idazolyl-substituted lower alkyl group which may have phenyl-lower alkyl group(s) as the substituent(s) on the imidazolyl ring,or a group of the formula: -C-N (wherein R5 and R6_ R6 are the same or different and are each a hydrogen atom, a benzothiazolyl group, or a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a lower alkoxy group, a phenyl-lower alkoxy group, a lower alkyl group and a hydroxyl group; further, said 5 and R6 and the adjacent nitrogen atom bonding thereto may form, together with or without other nitrogen atom or an oxygen atom, a 5- to 6-membered saturated heterocyclic group; said heterocyclic group may have, as the substituent(s) , phenyl group(s) which may have lower alkoxy group(s) as the substituent(s) on the phenyl ring);R3 is a hydrogen atom, a lower alkyl group or a phenyl-lower alkyl group; andR4 is a hydroxyl group, a phenyl-lower alkoxy group or a tetrahydropyranyloxy group; and 
wherein R? is a lower alkyl group, a phenyl-lower alkyl group which may have, on the phenyl ring, substituent(s) selected from the group consisting of a hydroxyl group and a phenyl-lower alkoxy group, a lower alkylthio group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a lower alkoxycarbonyl group, a lower alkoxycarbonyl group- substituted lower alkyl group or a hydroxyl group- substituted lower alkyl group; R8 is a hydrogen atom; further R7 and R8 may form a trimethylene group together; andR9 is a hydroxyl group or a
</DESCRIPTION>
<CLAIMS>
 CLAIMS 1. At least one piperazine derivative selected from the group consisting of piperazine derivatives represented by the general formula (1):
wherein Rl is a lower alkyl group;
R2 is a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a hydroxyl group, a phenyl- lower alkoxy group, a lower alkyl group, a lower alkoxy group and a halogen atom, an imidazolyl-substituted lower alkyl group which may have phenyl-lower alkyl group(s) as the substituent(s) on the imidazolyl ring,
or a group of the formula: R5 and R6

 are the same or different, and are each a hydrogen atom, a benzothiazolyl group, or a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents -selected from the group consisting of a lower alkoxy group, a phenyl-lower alkoxy group, a lower alkyl group and a hydroxyl group; further, said R5 and R6 and the o adjacent nitrogen atom being bonded thereto, together with or without other nitrogen atom or an oxygen atom. 


may form a 5- to 6-membered saturated heterocyclic group; said heterocyclic group may have, as the substituent(s), phenyl group(s) which may have lower alkoxy group(s) as the substituent(s) on the phenyl ring);
R3 is a hydrogen atom, a lower alkyl group or a phenyl-lower alkyl group; and
R4 is a hydroxyl group, a phenyl-lower alkoxy group or a tetrahydropyranyloxy group; and a piperazine derivative represented by the general formula (2):
wherein R7 is a lower alkyl group, a phenyl-lower alkyl group which may have, on the phenyl ring, substituent(s) selected from the group consisting of a hydroxyl group and a phenyl-lower alkoxy group, a lower alkylthio group- substituted lower alkyl group, a phenyl-lower alkoxy group- substituted lower alkyl group, a lower alkoxycarbonyl group, a lower alkoxycarbonyl group- substituted lower alkyl group or a hydroxyl group- substituted lower alkyl group; R
8
 is a hydrogen atom; further R7 and R8 may form a trimethylene group by combining together; and 


 R
9
 is a hydroxyl group or a phenyl-lower alkoxy group; or salt thereof.
2. The piperazine derivative or salt thereof according to Claim 1, wherein the piperazine derivative is represented by the general (1):
wherein Rl is a lower alkyl group;
R2 is a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a hydroxyl group, a phenyl- lower alkoxy group, a lower alkyl group, a lower alkoxy group and a halogen atom, an imidazolyl-substituted lower alkyl group which may have phenyl-lower alkyl group(s) as the substituent(s) on the imidazolyl ring,
or a group of the formula: R5 and R6

 are the same or different, and are each a hydrogen atom, a benzthiazolyl group, or a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a lower alkoxyl group, a phenyl-lower alkoxyl group, a lower alkyl group and a hydroxyl group; further, said R5 and R6 and the adjacent nitrogen atom being bonded thereto, together 


with or without other nitrogen atom or an oxygen atom, may form a 5- to 6-membered saturated heterocyclic group; said heterocyclic group may have, as the substituent(s) , phenyl group(s) which may have lower alkoxy group(s) as the substituent(s) on the phenyl ring);
R3 is a hydrogen atom, a lower alkyl group or a phenyl-lower alkyl group; and
R4 is a hydroxyl group, a phenyl-lower alkoxy group or a tetrahydropyranyloxy group or a salt thereof. 3. The piperazine derivative or salt thereof according to Claim 1, wherein the piperazine derivative is represented by the general formula (2):
wherein R7 is a lower alkyl group, a phenyl-lower alkyl group which may have, on the phenyl ring, substituent(s) selected from the group consisting of a hydroxyl group and a phenyl-lower alkoxy group, a lower alkylthio group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a lower alkoxycarbonyl group, a lower alkoxycarbonyl group- substituted lower alkyl group or a hydroxyl group- substituted lower alkyl group; 


 R8 is a hydrogen atom; further R7 and 8 may form a trimethylene group by combining together; and
R9 is a hydroxyl group or a phenyl-lower alkoxy group. 4. The piperazine derivative or salt thereof according to Claim 2, wherein R2 is a phenyl-lower alkyl group which may have, on the phenyl ring, 1 to 3 substituents selected from the group consisting of a hydroxyl group, a phenyl-lower alkoxyl group, a lower alkyl group, a lower alkoxy group and a halogen atom.
5. The piperazine derivative or salt thereof according to Claim 2, wherein R2 is an imidazolyl- substituted lower alkyl group which may have phenyl- lower alkyl group(s) as the substituent(s) on the imidazolyl ring.
6. The piperazine derivative or salt thereof according to Claim 2, wherein R is a group of the
formula: (wherein R5 and R6 are the same as

 defined above) . 7. The piperazine derivative or salt thereof according to Claim 4, wherein R3 is a hydrogen atom.
8. The piperazine derivative or salt thereof according to Claim 4, wherein R3 is a lower alkyl group or a phenyl-lower alkyl group. 
9
Â« The piperazine derivative or salt thereof according to Claim 5, wherein R3 is a hydrogen atom. 


10. The piperazine derivative or salt thereof according to Claim 5, wherein R3 is a lower alkyl group or a phenyl-lower alkyl group.
11. The piperazine derivative or salt thereof according to Claim 6, wherein R3 is a hydrogen atom.
12. The piperazine derivative or salt thereof according to Claim 6, wherein R3 is a lower alkyl group or a phenyl-lower alkyl group.
13. The piperazine derivative or salt thereof according to Claims 7 to 12, wherein R-* is a hydroxyl group.
14. The piperazine derivative or salt thereof according to Claims 7 to 12, wherein R* is a phenyl- lower alkoxy group or a tetrahydropyranyloxy group. 15. The piperazine derivative or salt thereof according to Claim 3, wherein R7 is a lower alkoxycarbonyl group-substituted lower alkyl group.
16. The piperazine derivative or salt thereof according to Claim 3, wherein R7 and R8 form a trimethylene group by combining thereof.
17. The piperazine derivative or salt thereof according to Claim 3, wherein R7 is a lower alkyl group, a phenyl-lower alkyl group which may have, on the phenyl ring, substituent(s) selected from the group consisting of a hydroxyl group and a phenyl-lower alkoxyl group, a lower alkylthio group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl 


group, a lower alkoxycarbonyl group, or a hydroxyl group-substituted lower alkyl group.
18. The piperazine derivative or salt thereof according to Claims 15 to 17, wherein R9 is a hydroxyl group.
19. The piperazine derivative or salt thereof according to Claims 15 to 17, wherein R9 is a phenyl- lower alkoxy group.
20. (3RS, 6RS)-l-Hydroxy-3-(3,5-di-tert-butyl-4- hydroxybenzyl)-6-isobutylpiperazin-2,5-dione.
21. (3RS, 6SR)-l-Hydroxy-3-(3,5-di-tert-butyl-4- hydroxybenzyl)-6-isobutylpiperazin-2,5-dione.
22. (3RS, 6RS)-l-Hydroxy-6-(3-indolylmethyl)-3- ethoxycarbonylmethylpiperazin-2,5-dione. 23. (3RS, 6SR)-l-Hydroxy-6-(3-indolylmethyl)-3- ethoxycarbonylmethylpiperazin-2,5-dione.
24. (3S, 6R)-l-Hydroxy-6-(3-indolylmethyl)-3- ethoxycarbonylmethylpiprazin-2,5-dione.
25. An agent for inhibiting superoxide radicals which contains, as the active ingredient, a piperazine derivative or salt thereof as claimed in Claim 1.
26. The agent for inhibiting superoxide radicals according to Claim 25, wherein the active agent is a piperazine derivative or salt thereof as claimed in Claim 2.
27. The agent for inhibiting superoxide radicals according to Claim 25, wherein the active agent is a 


piperazine derivative or salt thereof as claimed in Claim 3.
28. An agent for preventing and treating diseases or symptoms being caused by superoxide radicals which contains, as the active ingredient, a piperazine derivaÂ¬ tive or salt thereof as claimed in Claim 1.
29. The agent for preventing and treating diseases or symptoms being caused by superoxide radicals accordÂ¬ ing to Claim 28, wherein the active ingredient is a piperazine derivative or salt thereof as claimed in Claim 2.
30. The agent for preventing and treating diseases or symptoms being caused by superoxide radicals accordÂ¬ ing to Claim 28, wherein the active ingredient is a piperazine derivative or salt thereof as claimed in Claim 3.
31. An agent for preventing and treating nephritis which contains, as the active ingredient, a piperazine derivative or salt thereof as claimed in Claim 1. 32. The agent for preventing and treating nephritis according to Claim 31, wherein the active ingredient is a piperazine derivative or salt thereof as claimed in Claim 2. 33. The agent for preventing and treating nephritis according to Claim 31, wherein the active ingredient is a piperazine derivative or salt thereof as claimed in Claim 3. 


34. Process for preparing a compound of the formula (la):
(wherein Rl, R3, R4, R5 and R6 are the same as defined above), by reacting a compound of the formula (3):
(wherein Ri, R3 and R are the same as defined above), with a compound of the formula (4):
^
R5
HN (4) "R6
(wherein R5 and R6 are the same as defined above).
35. Process for preparing a piperazine derivative of the formula (1):
(wherein Ri, R2, R3 and R4 are the same as defined above), by converting a compound of the formula (16): 

(wherein Ri, R2, R3 and R4 are the same as defined above), into the piperazine derivative of the formula
(1).
36. Process for preparing a piperazine derivative of the formula (1):
(wherein Ri, R2, R3 and R4 are the same as defined above), by converting a compound of the formula (22) or (23):
(wherein Ri, R2, R3 and R4 are the same as defined above; and RA is a hydrogen atom or RiOa (wherein RiOa i
s

a lower alkyl group) ) , into the piprazine derivative of the formula (1) .
37. Process for preparing a piperazine derivative of the formula (2):
(wherein R7, R8 and R- are the same as defined above), by converting a compound of the formula (26):
(26) 

(wherein R?, R8, R9 and R o* are the same as defined above), into the piperazine derivative of the formula (2). 38. Process for preparing a piprazine derivative of the formula (2):
(2)

(wherein R7, R8 and R
9
 are the same as defined above), by converting a compound of the formula (29):
(wherein R7, R8 and R- are the same as defined above), into the piperazine derivative of the formula (2). 

</CLAIMS>
</TEXT>
</DOC>
